Virtual research studies, clinical trials & surveys are possible
during the coronavirus pandemic with Mitra® - our remote
specimen collection devices powered by VAMS® technology!
In the US, use of the Mitra device with blood is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device is approved as a remote blood sample collection device for some clinical applications, as referenced in the content included here.
In this “SeroSurvey,” researchers will collect blood samples using Mitra blood collection kits from Neoteryx and analyze those samples from 10,000 volunteers to provide critical data for epidemiological models. Results will examine antibodies against COVID-19 and help illuminate the extent to which the novel coronavirus has spread undetected.
Neoteryx’s Technical Director highlights several study papers in peer-reviewed publications to provide a summary of research studies using extraction methodology for Mitra remote specimen sampling devices in ligand binding assays.
As researchers around the world race to respond to the COVID-19 pandemic, UR CTSI Co-Director Martin Zand, M.D., Ph.D., is rapidly adapting previous research to develop a potential diagnostic test that would require just a few drops of blood to detect the fast-spreading disease.
This study successfully measures immunity for up to 33 strains of influenza virus. Twenty-one healthy volunteers were used to evaluate the feasibility of combining the benefits of at-home specimen sampling, with the mPlex-Flu assay.
Wake Forest Baptist Health will begin a year-long random sample of its patients looking for coronavirus antibodies, an attempt to get a sense of how widespread the virus is and was in North Carolina. Neoteryx specimen collection kits will be used in the study to sample 300 people in each of 40 counties — 20 served by Wake Forest Baptist Health and 20 served by Atrium — to build a large enough population.
Neoteryx’s Technical Director highlights the study details of the paper: Wang J, et. al (2019) Application of VAMS to measure multidimensional anti-influenza IgG antibodies by the mPlex-Flu assay. Journal of Clinical and Translational Science, 3: 332–343.
Phosphorous is currently enrolling research participants in its study focused on validation of at-home collection of specimen samples that will be sent back to the lab and used for the diagnosis of COVID-19 Infection via RT-qPCR and serum antibodies.
Neoteryx’s Technical Director highlights the study details of the paper: Qu. Y, et. al (2017) Capillary Specimen Collected on a Volumetric Absorptive Microsampling (VAMS) Device for Monitoring Hydroxychloroquine in Rheumatoid Arthritis Patients. Journal of Pharmaceutical and Biomedical Analysis, 140: 334–341.
It is thought that inflammation and cytokines play a role in COVID-19 illness, and our understanding of this will inform how we can treat COVID-19 patients.
This easy-to-use format has two sampling devices, includes barcoding, and is enclosed in a specimen bag for convenient transport.
This low-budget specimen collection format works well for pilot studies, proof-of-concept testing, and clinical research with limited funding.
The 96-autorack enables high throughput sample processing for liquid extractions, analytical method development, and setting up QCs/Calibrators.
The Clamshell and Cartridge Mitra formats are available packaged in collection kits that include instructions, lancets, and other supplies. Kits can be customized to your needs.
Neoteryx created the Mitra® Microsampler with you in mind.
Whether you are a research scientist, clinical trial manager, lab director or technician, there is a Mitra Microsampler that will work for you.
We'll help you select the device format that fits you best via a quick conversation with a Microsampling Consultant.